Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer-Reference-Cited by-同舟云学术

Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer

Published:2016-08-03 Issue:1 Volume:20 Page:1-7
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Clopes Ana¹,Gasol Montse²,Cajal Rosana³,Segú Luis⁴,Crespo Ricard¹,Mora Ramón²,Simon Susana³,Cordero Luis A³,Calle Candela¹,Gilabert Antoni²,Germà Josep R¹

Affiliation:

1. Catalan Institute of Oncology, Barcelona, Spain;

2. Catalan Health Service, Barcelona, Spain;

3. AstraZeneca, Madrid, Spain;

4. Oblikue Consulting, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1215991

Reference21 articles.

1. Esquemas innovadores de mejora del acceso al mercado de nuevas tecnologías: los acuerdos de riesgo compartido

2. Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers

3. Risk-Sharing Arrangements That Link Payment For Drugs To Health Outcomes Are Proving Hard To Implement

4. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

5. Pugatch M, Healy P, Chu R. Sharing the burden: could risk sharing change the way we pay for healthcare? Available at: http://www.stockholm-network.org/downloads/publications/Sharing_the_Burden.pdf [Last accessed 15 May 2015]

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy;JAMA Health Forum;2023-12-28

2. Should Canada adopt managed access agreements in Canada for expensive drugs?;Journal of Law and the Biosciences;2023-01-01

3. Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook;Drug Discovery Today;2023-01

4. Demonstrating proof of concept for value-based agreements in Europe: two real-world cases;International Journal of Technology Assessment in Health Care;2023

5. Esquemas de pago basados en resultados de medicamentos: experiencia de 10 años en un centro monográfico de cáncer;Medicina Clínica;2022-05